New stent gamechanger for patients

Research Updates
A new stent, which dissolves in the heart after fixing blocked arteries, is now more easily accessible to Australians. Dr Sanjay Patel, cardiologist and HRI Cell Therapeutics Group Leader spoke to Gabriella Rogers at Channel 9. 

Stents are used in patients with narrowings or blockages in their coronary arteries, causing problems such as chest discomfort, shortness of breath, or in patients that present with a heart attack. While standard stents are made of metal and are permanent implants, these new biodegradable stents dissolve. 

According to Dr Sanjay Patel, "They disappear within three, four, five years, and that's advantageous, because we don't want to leave metal behind."

Watch the video above. 
Previous
Next

Related news

Crystal ball molecule predicts diabetes before it strikes

HRI researchers have developed a simple test to predict diabetes more than a decade before it strikes, a breakthrough that could help ease the impending diabetes epidemic. The team has uncovered an important molecule found in liver fat that can identify who is most at risk of developing diabetes and other cardio-metabolic disorders like liver disease.  

Read more

New drug hope to target silent killer

An exciting new treatment for very high blood pressure is on the horizon after a world-first discovery by Heart Research Institute scientists, who have uncovered a brain chemical instrumental in triggering hypertension, the so-called silent killer responsible for the deaths of thousands of Australians each year.

The researchers are optimistic the results, published this week in the American Journal of Physiology-Heart and Circulatory Physiology, will ultimately lead to a powerful new treatment that blocks a neurotransmitter and frees patients from the dangers of hypertension. 

Read more

Gout drug mends broken hearts

A drug used to treat arthritis has been found to clear clogged arteries in heart attack survivors, world-first Australian research shows.

The landmark discovery by Associate Professor Sanjay Patel, Leader of the Cell Therapeutics Group, and his team at the HRI paves the way for a cheap, simple and effective treatment regime that could protect thousands of Australian heart patients from future attacks that might kill them or further damage their heart. 

Read more